Technical Signs Every Trader Should Know: Digital Power Corporation (DPW), Imprimis Pharmaceuticals, Inc. (IMMY)

Digital Power Corporation (NYSE:DPW) traded at an unexpectedly low level on 10/27/2017 when the stock experienced a 5.11% gain to a closing price of $0.65. The company saw 0.41 million shares trade hands over the course of the day. Given that its average daily volume over the 30 days has been 446.79 million shares a day, this signifies a pretty significant change over the norm.

Earlier this month, DPW issued an investor update stating that effective October 6, 2017, William B. Horne, a member of the Board of Directors, has been appointed Chief Financial Officer for Digital Power Corporation. Mr. Horne will remain a member of the Board of Directors and replaces Mr. Amos Kohn who served as interim Chief Financial Officer.

The Company was also pleased to report a few changes with its Board of Directors including the addition of its newest independent director, Jeff Bentz. Mr. Bentz is an experienced businessman who has served since 1994 as President of North Star Terminal & Stevedore Company, a full-service stevedoring company located in Alaska and whose major areas of business include terminal operations and management, stevedore services, and heavy equipment operations. He also has served as a director and advisor to several private companies and agencies. Bentz replaces Kristine L. Ault who concurrently resigned from the Board of Directors and was thanked by the Company for her service and support for the past year.

Robert Smith, one of the other independent members of the Board of Directors, was appointed Chair of the Audit Committee, replacing Mr. Horne. Mr. Smith is one of the original Founders and a former CEO and Chairman of the Company and brings a unique insight to the operations of the Company and its history.

As previously reported, subject to shareholder approval, the Company will be undergoing a corporate reorganization, including the reincorporation from the State of California to the State of Delaware and changing its name to DPW Holdings, Inc. to better reflect its new business model as a holding company. In connection with the reorganization, the Company will retain its stock symbol. The Company shareholders will be receiving a proxy statement which will discuss in detail these and other important issues to be voted upon at its annual shareholders meeting.

The Company is committed to an acquisitions and organic growth strategy and anticipates continuing to raise additional capital in the foreseeable future to fuel the engine of growth necessary to accomplish the Company’s goals and strategy.

Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY)’s Lead Over its Technicals

On the other hand, Imprimis Pharmaceuticals, Inc. by far traveled 12.14% versus a 1-year low price of $1.40. The share price was last seen -4.27% lower, reaching at $1.57 on Oct. 27, 2017. At recent session, the prices were hovering between $1.55 and $1.67. This company shares are 218.47% off its target price of $5 and the current market capitalization stands at $32.91M. The recent change has given its price a -10.78% deficit over SMA 50 and -66.52% deficit over its 52-week high. The stock witnessed -5.42% declines, -39.15% declines and -62.8% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found IMMY’s volatility during a week at 8.11% and during a month it has been found around 12.15%.

Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) Intraday Metrics

Imprimis Pharmaceuticals, Inc. (IMMY) exchanged hands at an unexpectedly low level of 0.25 million shares over the course of the day. Noting its average daily volume at 590.67 million shares each day over the month, this signifies a pretty significant change over the norm.

SHARE